| Sustained small interfering RNA delivery by mesoporous silicon particles T Tanaka, LS Mangala, PE Vivas-Mejia, R Nieves-Alicea, AP Mann, ... Cancer research 70 (9), 3687-3696, 2010 | 374 | 2010 |
| Antibiotic-loaded nanoparticles targeted to the site of infection enhance antibacterial efficacy S Hussain, J Joo, J Kang, B Kim, GB Braun, ZG She, D Kim, AP Mann, ... Nature biomedical engineering 2 (2), 95-103, 2018 | 345 | 2018 |
| Nanomedicine in cancer therapy: innovative trends and prospects E Blanco, A Hsiao, AP Mann, MG Landry, F Meric‐Bernstam, M Ferrari Cancer science 102 (7), 1247-1252, 2011 | 321 | 2011 |
| Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-κB in cancer cells: delineation of a novel pathway AP Mann, A Verma, G Sethi, B Manavathi, H Wang, JY Fok, ... Cancer research 66 (17), 8788-8795, 2006 | 272 | 2006 |
| Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis A Verma, H Wang, B Manavathi, JY Fok, AP Mann, R Kumar, K Mehta Cancer research 66 (21), 10525-10533, 2006 | 217 | 2006 |
| Etchable plasmonic nanoparticle probes to image and quantify cellular internalization GB Braun, T Friman, HB Pang, A Pallaoro, TH De Mendoza, ... Nature materials 13 (9), 904-911, 2014 | 206 | 2014 |
| A peptide for targeted, systemic delivery of imaging and therapeutic compounds into acute brain injuries AP Mann, P Scodeller, S Hussain, J Joo, E Kwon, GB Braun, T Mölder, ... Nature communications 7 (1), 11980, 2016 | 201 | 2016 |
| E‐Selectin‐targeted porous silicon particle for nanoparticle delivery to the bone marrow AP Mann, T Tanaka, A Somasunderam, X Liu, DG Gorenstein, M Ferrari Advanced Materials 36 (23), H278-H282, 2011 | 151 | 2011 |
| Identification of thioaptamer ligand against E-selectin: potential application for inflamed vasculature targeting AP Mann, A Somasunderam, R Nieves-Alicea, X Li, A Hu, AK Sood, ... PloS one 5 (9), e13050, 2010 | 124 | 2010 |
| Combinatorial selection of DNA thioaptamers targeted to the HA binding domain of human CD44 A Somasunderam, V Thiviyanathan, T Tanaka, X Li, M Neerathilingam, ... Biochemistry 49 (42), 9106-9112, 2010 | 108 | 2010 |
| Thioaptamer conjugated liposomes for tumor vasculature targeting AP Mann, RC Bhavane, A Somasunderam, BL Montalvo-Ortiz, ... Oncotarget 2 (4), 298, 2010 | 105 | 2010 |
| Porous silicon–graphene oxide core–shell nanoparticles for targeted delivery of siRNA to the injured brain J Joo, EJ Kwon, J Kang, M Skalak, EJ Anglin, AP Mann, E Ruoslahti, ... Nanoscale horizons 1 (5), 407-414, 2016 | 102 | 2016 |
| Identification of a peptide recognizing cerebrovascular changes in mouse models of Alzheimer’s disease AP Mann, P Scodeller, S Hussain, GB Braun, T Mölder, K Toome, ... Nature communications 8 (1), 1403, 2017 | 69 | 2017 |
| Blocking the adhesion cascade at the premetastatic niche for prevention of breast cancer metastasis SA Kang, N Hasan, AP Mann, W Zheng, L Zhao, L Morris, W Zhu, ... Molecular Therapy 23 (6), 1044-1054, 2015 | 64 | 2015 |
| Immune‐mediated ECM depletion improves tumour perfusion and payload delivery YL Yeow, VR Kotamraju, X Wang, M Chopra, N Azme, J Wu, TD Schoep, ... EMBO molecular medicine 11 (12), e10923, 2019 | 34 | 2019 |
| E-selectin: its role in cancer and potential as a biomarker AP Mann, T Tanaka Transl. Med. S 1, 2161-1025, 2011 | 21 | 2011 |
| Safety evaluation of intravenously administered mono-thioated aptamer against E-selectin in mice SA Kang, B Tsolmon, AP Mann, W Zheng, L Zhao, YD Zhao, DE Volk, ... Toxicology and applied pharmacology 287 (1), 86-92, 2015 | 16 | 2015 |
| Vascular changes in tumors resistant to a vascular disrupting nanoparticle treatment S Sharma, AP Mann, T Mölder, VR Kotamraju, R Mattrey, T Teesalu, ... Journal of Controlled Release 268, 49-56, 2017 | 9 | 2017 |
| Mesoporous silicon particles for sustained gene silencing N Hasan, A Mann, M Ferrari, T Tanaka Ovarian Cancer: Methods and Protocols, 481-493, 2013 | 7 | 2013 |
| A Cyclic Peptide Targets Glioblastoma by Binding to Aberrantly Exposed SNAP25 AG Arias, L Tovar-Martinez, EK Asciutto, A Mann, K Posnograjeva, ... Molecular pharmaceutics 22 (1), 363-376, 2024 | 1 | 2024 |
